ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Multiple Sclerosis Treatment Market Insights, Forecast to 2029
Published Date: August 2023
|
Report Code: QYRE-Auto-0D513
Home | Market Reports | Health| Health Conditions| Neurological Conditions
Global Multiple Sclerosis Treatment Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Multiple Sclerosis Treatment Market Insights, Forecast to 2029

Code: QYRE-Auto-0D513
Report
August 2023
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bayer
Pfizer Inc
Novartis
Merck
Teva Pharmaceutical
Sanofi
Biogen
Roche
Cinnagen
Mylan NV
Bristol–Myers Squibb
Janssen Pharmaceuticals
Acorda Therapeutics

Multiple Sclerosis Treatment Market Size

The global Multiple Sclerosis Treatment market is projected to grow from US$ 17750 million in 2023 to US$ 19990 million by 2029, at a Compound Annual Growth Rate (CAGR) of 2.0% during the forecast period.

Multiple Sclerosis Treatment Market

Multiple Sclerosis Treatment Market

Multiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged. This damage disrupts the ability of parts of the nervous system to communicate, resulting in a range of signs and symptoms, including physical, mental, and sometimes psychiatric problems. Specific symptoms can include double vision, blindness in one eye, muscle weakness, trouble with sensation, or trouble with coordination. MS takes several forms, with new symptoms either occurring in isolated attacks (relapsing forms) or building up over time (progressive forms). Between attacks, symptoms may disappear completely; however, permanent neurological problems often remain, especially as the disease advances.
Market Analysis and Insights: Global Multiple Sclerosis Treatment Market
Although there is no known cure for multiple sclerosis, several therapies have proven helpful. The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. Starting medications is generally recommended in people after the first attack when more than two lesions are seen on MRI.
Report Includes
This report presents an overview of global market for Multiple Sclerosis Treatment market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Multiple Sclerosis Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Multiple Sclerosis Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Multiple Sclerosis Treatment revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Multiple Sclerosis Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by sales channel, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Multiple Sclerosis Treatment revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Pfizer, Merck & Co, Teva Pharmaceutical, Sanofi, Bayer, Biogen, Roche, Novartis and CinnaGen, etc.

Scope of Multiple Sclerosis Treatment Market Report

Report Metric Details
Report Name Multiple Sclerosis Treatment Market
Accounted market size in 2023 US$ 17750 million
Forecasted market size in 2029 US$ 19990 million
CAGR 2.0
Base Year 2023
Forecasted years 2023 - 2029
Segment by Type
  • Immunomodulatory
  • Immunosuppressive
  • Interferons
  • Others
Segment by Sales Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Stores
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Merck & Co, Teva Pharmaceutical, Sanofi, Bayer, Biogen, Roche, Novartis, CinnaGen, Mylan, Bristol-Myers Squibb, Janssen Pharmaceuticals, Acorda Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Multiple Sclerosis Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Multiple Sclerosis Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by sales channel, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America by type, by sales channel and by country, revenue for each segment.
  • Chapter 7: Europe by type, by sales channel and by country, revenue for each segment.
  • Chapter 8: China by type and by sales channel revenue for each segment.
  • Chapter 9: Asia (excluding China) by type, by sales channel and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by type, by sales channel and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Multiple Sclerosis Treatment revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Multiple Sclerosis Treatment Market growing?

Ans: The Multiple Sclerosis Treatment Market witnessing a CAGR of 2.0 during the forecast period 2023-2029.

What is the Multiple Sclerosis Treatment Market size in 2029?

Ans: The global Multiple Sclerosis Treatment market is projected to grow from US$ 17750 million in 2023 to US$ 19990 million by 2029, at a Compound Annual Growth Rate (CAGR) of 2.0% during the forecast period.

Who are the main players in the Multiple Sclerosis Treatment Market report?

Ans: The main players in the Multiple Sclerosis Treatment Market are Pfizer, Merck & Co, Teva Pharmaceutical, Sanofi, Bayer, Biogen, Roche, Novartis, CinnaGen, Mylan, Bristol-Myers Squibb, Janssen Pharmaceuticals, Acorda Therapeutics

What are the Type segmentation covered in the Multiple Sclerosis Treatment Market report?

Ans: The Types covered in the Multiple Sclerosis Treatment Market report are Immunomodulatory, Immunosuppressive, Interferons, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multiple Sclerosis Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Immunomodulatory
1.2.3 Immunosuppressive
1.2.4 Interferons
1.2.5 Others
1.3 Market by Sales Channel
1.3.1 Global Multiple Sclerosis Treatment Market Size Growth Rate by Sales Channel, 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Stores
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Multiple Sclerosis Treatment Market Perspective (2018-2029)
2.2 Global Multiple Sclerosis Treatment Growth Trends by Region
2.2.1 Multiple Sclerosis Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Multiple Sclerosis Treatment Historic Market Size by Region (2018-2023)
2.2.3 Multiple Sclerosis Treatment Forecasted Market Size by Region (2024-2029)
2.3 Multiple Sclerosis Treatment Market Dynamics
2.3.1 Multiple Sclerosis Treatment Industry Trends
2.3.2 Multiple Sclerosis Treatment Market Drivers
2.3.3 Multiple Sclerosis Treatment Market Challenges
2.3.4 Multiple Sclerosis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Multiple Sclerosis Treatment by Players
3.1.1 Global Multiple Sclerosis Treatment Revenue by Players (2018-2023)
3.1.2 Global Multiple Sclerosis Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Multiple Sclerosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Multiple Sclerosis Treatment, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Multiple Sclerosis Treatment Market Concentration Ratio
3.4.1 Global Multiple Sclerosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multiple Sclerosis Treatment Revenue in 2022
3.5 Global Key Players of Multiple Sclerosis Treatment Head office and Area Served
3.6 Global Key Players of Multiple Sclerosis Treatment, Product and Application
3.7 Global Key Players of Multiple Sclerosis Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Multiple Sclerosis Treatment Breakdown Data by Type
4.1 Global Multiple Sclerosis Treatment Historic Market Size by Type (2018-2023)
4.2 Global Multiple Sclerosis Treatment Forecasted Market Size by Type (2024-2029)
5 Multiple Sclerosis Treatment Breakdown Data by Sales Channel
5.1 Global Multiple Sclerosis Treatment Historic Market Size by Sales Channel (2018-2023)
5.2 Global Multiple Sclerosis Treatment Forecasted Market Size by Sales Channel (2024-2029)
6 North America
6.1 North America Multiple Sclerosis Treatment Market Size (2018-2029)
6.2 North America Multiple Sclerosis Treatment Market Size by Type
6.2.1 North America Multiple Sclerosis Treatment Market Size by Type (2018-2023)
6.2.2 North America Multiple Sclerosis Treatment Market Size by Type (2024-2029)
6.2.3 North America Multiple Sclerosis Treatment Market Share by Type (2018-2029)
6.3 North America Multiple Sclerosis Treatment Market Size by Sales Channel
6.3.1 North America Multiple Sclerosis Treatment Market Size by Sales Channel (2018-2023)
6.3.2 North America Multiple Sclerosis Treatment Market Size by Sales Channel (2024-2029)
6.3.3 North America Multiple Sclerosis Treatment Market Share by Sales Channel (2018-2029)
6.4 North America Multiple Sclerosis Treatment Market Size by Country
6.4.1 North America Multiple Sclerosis Treatment Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Multiple Sclerosis Treatment Market Size by Country (2018-2023)
6.4.3 North America Multiple Sclerosis Treatment Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Multiple Sclerosis Treatment Market Size (2018-2029)
7.2 Europe Multiple Sclerosis Treatment Market Size by Type
7.2.1 Europe Multiple Sclerosis Treatment Market Size by Type (2018-2023)
7.2.2 Europe Multiple Sclerosis Treatment Market Size by Type (2024-2029)
7.2.3 Europe Multiple Sclerosis Treatment Market Share by Type (2018-2029)
7.3 Europe Multiple Sclerosis Treatment Market Size by Sales Channel
7.3.1 Europe Multiple Sclerosis Treatment Market Size by Sales Channel (2018-2023)
7.3.2 Europe Multiple Sclerosis Treatment Market Size by Sales Channel (2024-2029)
7.3.3 Europe Multiple Sclerosis Treatment Market Share by Sales Channel (2018-2029)
7.4 Europe Multiple Sclerosis Treatment Market Size by Country
7.4.1 Europe Multiple Sclerosis Treatment Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Multiple Sclerosis Treatment Market Size by Country (2018-2023)
7.4.3 Europe Multiple Sclerosis Treatment Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Multiple Sclerosis Treatment Market Size (2018-2029)
8.2 China Multiple Sclerosis Treatment Market Size by Type
8.2.1 China Multiple Sclerosis Treatment Market Size by Type (2018-2023)
8.2.2 China Multiple Sclerosis Treatment Market Size by Type (2024-2029)
8.2.3 China Multiple Sclerosis Treatment Market Share by Type (2018-2029)
8.3 China Multiple Sclerosis Treatment Market Size by Sales Channel
8.3.1 China Multiple Sclerosis Treatment Market Size by Sales Channel (2018-2023)
8.3.2 China Multiple Sclerosis Treatment Market Size by Sales Channel (2024-2029)
8.3.3 China Multiple Sclerosis Treatment Market Share by Sales Channel (2018-2029)
9 Asia (excluding China)
9.1 Asia Multiple Sclerosis Treatment Market Size (2018-2029)
9.2 Asia Multiple Sclerosis Treatment Market Size by Type
9.2.1 Asia Multiple Sclerosis Treatment Market Size by Type (2018-2023)
9.2.2 Asia Multiple Sclerosis Treatment Market Size by Type (2024-2029)
9.2.3 Asia Multiple Sclerosis Treatment Market Share by Type (2018-2029)
9.3 Asia Multiple Sclerosis Treatment Market Size by Sales Channel
9.3.1 Asia Multiple Sclerosis Treatment Market Size by Sales Channel (2018-2023)
9.3.2 Asia Multiple Sclerosis Treatment Market Size by Sales Channel (2024-2029)
9.3.3 Asia Multiple Sclerosis Treatment Market Share by Sales Channel (2018-2029)
9.4 Asia Multiple Sclerosis Treatment Market Size by Region
9.4.1 Asia Multiple Sclerosis Treatment Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Multiple Sclerosis Treatment Market Size by Region (2018-2023)
9.4.3 Asia Multiple Sclerosis Treatment Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Multiple Sclerosis Treatment Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Multiple Sclerosis Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Multiple Sclerosis Treatment Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Multiple Sclerosis Treatment Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Multiple Sclerosis Treatment Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Multiple Sclerosis Treatment Market Size by Sales Channel
10.3.1 Middle East, Africa, and Latin America Multiple Sclerosis Treatment Market Size by Sales Channel (2018-2023)
10.3.2 Middle East, Africa, and Latin America Multiple Sclerosis Treatment Market Size by Sales Channel (2024-2029)
10.3.3 Middle East, Africa, and Latin America Multiple Sclerosis Treatment Market Share by Sales Channel (2018-2029)
10.4 Middle East, Africa, and Latin America Multiple Sclerosis Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Multiple Sclerosis Treatment Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Multiple Sclerosis Treatment Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Multiple Sclerosis Treatment Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Multiple Sclerosis Treatment Introduction
11.1.4 Pfizer Revenue in Multiple Sclerosis Treatment Business (2018-2023)
11.1.5 Pfizer Recent Developments
11.2 Merck & Co
11.2.1 Merck & Co Company Details
11.2.2 Merck & Co Business Overview
11.2.3 Merck & Co Multiple Sclerosis Treatment Introduction
11.2.4 Merck & Co Revenue in Multiple Sclerosis Treatment Business (2018-2023)
11.2.5 Merck & Co Recent Developments
11.3 Teva Pharmaceutical
11.3.1 Teva Pharmaceutical Company Details
11.3.2 Teva Pharmaceutical Business Overview
11.3.3 Teva Pharmaceutical Multiple Sclerosis Treatment Introduction
11.3.4 Teva Pharmaceutical Revenue in Multiple Sclerosis Treatment Business (2018-2023)
11.3.5 Teva Pharmaceutical Recent Developments
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Multiple Sclerosis Treatment Introduction
11.4.4 Sanofi Revenue in Multiple Sclerosis Treatment Business (2018-2023)
11.4.5 Sanofi Recent Developments
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer Multiple Sclerosis Treatment Introduction
11.5.4 Bayer Revenue in Multiple Sclerosis Treatment Business (2018-2023)
11.5.5 Bayer Recent Developments
11.6 Biogen
11.6.1 Biogen Company Details
11.6.2 Biogen Business Overview
11.6.3 Biogen Multiple Sclerosis Treatment Introduction
11.6.4 Biogen Revenue in Multiple Sclerosis Treatment Business (2018-2023)
11.6.5 Biogen Recent Developments
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Multiple Sclerosis Treatment Introduction
11.7.4 Roche Revenue in Multiple Sclerosis Treatment Business (2018-2023)
11.7.5 Roche Recent Developments
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Multiple Sclerosis Treatment Introduction
11.8.4 Novartis Revenue in Multiple Sclerosis Treatment Business (2018-2023)
11.8.5 Novartis Recent Developments
11.9 CinnaGen
11.9.1 CinnaGen Company Details
11.9.2 CinnaGen Business Overview
11.9.3 CinnaGen Multiple Sclerosis Treatment Introduction
11.9.4 CinnaGen Revenue in Multiple Sclerosis Treatment Business (2018-2023)
11.9.5 CinnaGen Recent Developments
11.10 Mylan
11.10.1 Mylan Company Details
11.10.2 Mylan Business Overview
11.10.3 Mylan Multiple Sclerosis Treatment Introduction
11.10.4 Mylan Revenue in Multiple Sclerosis Treatment Business (2018-2023)
11.10.5 Mylan Recent Developments
11.11 Bristol-Myers Squibb
11.11.1 Bristol-Myers Squibb Company Details
11.11.2 Bristol-Myers Squibb Business Overview
11.11.3 Bristol-Myers Squibb Multiple Sclerosis Treatment Introduction
11.11.4 Bristol-Myers Squibb Revenue in Multiple Sclerosis Treatment Business (2018-2023)
11.11.5 Bristol-Myers Squibb Recent Developments
11.12 Janssen Pharmaceuticals
11.12.1 Janssen Pharmaceuticals Company Details
11.12.2 Janssen Pharmaceuticals Business Overview
11.12.3 Janssen Pharmaceuticals Multiple Sclerosis Treatment Introduction
11.12.4 Janssen Pharmaceuticals Revenue in Multiple Sclerosis Treatment Business (2018-2023)
11.12.5 Janssen Pharmaceuticals Recent Developments
11.13 Acorda Therapeutics
11.13.1 Acorda Therapeutics Company Details
11.13.2 Acorda Therapeutics Business Overview
11.13.3 Acorda Therapeutics Multiple Sclerosis Treatment Introduction
11.13.4 Acorda Therapeutics Revenue in Multiple Sclerosis Treatment Business (2018-2023)
11.13.5 Acorda Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Bayer
Pfizer Inc
Novartis
Merck
Teva Pharmaceutical
Sanofi
Biogen
Roche
Cinnagen
Mylan NV
Bristol–Myers Squibb
Janssen Pharmaceuticals
Acorda Therapeutics
List of Tables
    Table 1. Global Multiple Sclerosis Treatment Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
    Table 2. Key Players of Immunomodulatory
    Table 3. Key Players of Immunosuppressive
    Table 4. Key Players of Interferons
    Table 5. Key Players of Others
    Table 6. Global Multiple Sclerosis Treatment Market Size Growth Rate by Sales Channel (US$ Million), 2018 VS 2022 VS 2029
    Table 7. Global Multiple Sclerosis Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 8. Global Multiple Sclerosis Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 9. Global Multiple Sclerosis Treatment Market Share by Region (2018-2023)
    Table 10. Global Multiple Sclerosis Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 11. Global Multiple Sclerosis Treatment Market Share by Region (2024-2029)
    Table 12. Multiple Sclerosis Treatment Market Trends
    Table 13. Multiple Sclerosis Treatment Market Drivers
    Table 14. Multiple Sclerosis Treatment Market Challenges
    Table 15. Multiple Sclerosis Treatment Market Restraints
    Table 16. Global Multiple Sclerosis Treatment Revenue by Players (2018-2023) & (US$ Million)
    Table 17. Global Multiple Sclerosis Treatment Revenue Share by Players (2018-2023)
    Table 18. Global Top Multiple Sclerosis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Sclerosis Treatment as of 2022)
    Table 19. Global Multiple Sclerosis Treatment Industry Ranking 2021 VS 2022 VS 2023
    Table 20. Global 5 Largest Players Market Share by Multiple Sclerosis Treatment Revenue (CR5 and HHI) & (2018-2023)
    Table 21. Global Key Players of Multiple Sclerosis Treatment, Headquarters and Area Served
    Table 22. Global Key Players of Multiple Sclerosis Treatment, Product and Application
    Table 23. Global Key Players of Multiple Sclerosis Treatment, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Multiple Sclerosis Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 26. Global Multiple Sclerosis Treatment Revenue Market Share by Type (2018-2023)
    Table 27. Global Multiple Sclerosis Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 28. Global Multiple Sclerosis Treatment Revenue Market Share by Type (2024-2029)
    Table 29. Global Multiple Sclerosis Treatment Market Size by Sales Channel (2018-2023) & (US$ Million)
    Table 30. Global Multiple Sclerosis Treatment Revenue Share by Sales Channel (2018-2023)
    Table 31. Global Multiple Sclerosis Treatment Forecasted Market Size by Sales Channel (2024-2029) & (US$ Million)
    Table 32. Global Multiple Sclerosis Treatment Revenue Share by Sales Channel (2024-2029)
    Table 33. North America Multiple Sclerosis Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 34. North America Multiple Sclerosis Treatment Market Size by Type (2024-2029) & (US$ Million)
    Table 35. North America Multiple Sclerosis Treatment Market Size by Sales Channel (2018-2023) & (US$ Million)
    Table 36. North America Multiple Sclerosis Treatment Market Size by Sales Channel (2024-2029) & (US$ Million)
    Table 37. North America Multiple Sclerosis Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 38. North America Multiple Sclerosis Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 39. North America Multiple Sclerosis Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 40. Europe Multiple Sclerosis Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 41. Europe Multiple Sclerosis Treatment Market Size by Type (2024-2029) & (US$ Million)
    Table 42. Europe Multiple Sclerosis Treatment Market Size by Sales Channel (2018-2023) & (US$ Million)
    Table 43. Europe Multiple Sclerosis Treatment Market Size by Sales Channel (2024-2029) & (US$ Million)
    Table 44. Europe Multiple Sclerosis Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 45. Europe Multiple Sclerosis Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 46. Europe Multiple Sclerosis Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 47. China Multiple Sclerosis Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 48. China Multiple Sclerosis Treatment Market Size by Type (2024-2029) & (US$ Million)
    Table 49. China Multiple Sclerosis Treatment Market Size by Sales Channel (2018-2023) & (US$ Million)
    Table 50. China Multiple Sclerosis Treatment Market Size by Sales Channel (2024-2029) & (US$ Million)
    Table 51. Asia Multiple Sclerosis Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 52. Asia Multiple Sclerosis Treatment Market Size by Type (2024-2029) & (US$ Million)
    Table 53. Asia Multiple Sclerosis Treatment Market Size by Sales Channel (2018-2023) & (US$ Million)
    Table 54. Asia Multiple Sclerosis Treatment Market Size by Sales Channel (2024-2029) & (US$ Million)
    Table 55. Asia Multiple Sclerosis Treatment Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 56. Asia Multiple Sclerosis Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 57. Asia Multiple Sclerosis Treatment Market Size by Region (2024-2029) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Multiple Sclerosis Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Multiple Sclerosis Treatment Market Size by Type (2024-2029) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Multiple Sclerosis Treatment Market Size by Sales Channel (2018-2023) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Multiple Sclerosis Treatment Market Size by Sales Channel (2024-2029) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Multiple Sclerosis Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 63. Middle East, Africa, and Latin America Multiple Sclerosis Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Multiple Sclerosis Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 65. Pfizer Company Details
    Table 66. Pfizer Business Overview
    Table 67. Pfizer Multiple Sclerosis Treatment Product
    Table 68. Pfizer Revenue in Multiple Sclerosis Treatment Business (2018-2023) & (US$ Million)
    Table 69. Pfizer Recent Developments
    Table 70. Merck & Co Company Details
    Table 71. Merck & Co Business Overview
    Table 72. Merck & Co Multiple Sclerosis Treatment Product
    Table 73. Merck & Co Revenue in Multiple Sclerosis Treatment Business (2018-2023) & (US$ Million)
    Table 74. Merck & Co Recent Developments
    Table 75. Teva Pharmaceutical Company Details
    Table 76. Teva Pharmaceutical Business Overview
    Table 77. Teva Pharmaceutical Multiple Sclerosis Treatment Product
    Table 78. Teva Pharmaceutical Revenue in Multiple Sclerosis Treatment Business (2018-2023) & (US$ Million)
    Table 79. Teva Pharmaceutical Recent Developments
    Table 80. Sanofi Company Details
    Table 81. Sanofi Business Overview
    Table 82. Sanofi Multiple Sclerosis Treatment Product
    Table 83. Sanofi Revenue in Multiple Sclerosis Treatment Business (2018-2023) & (US$ Million)
    Table 84. Sanofi Recent Developments
    Table 85. Bayer Company Details
    Table 86. Bayer Business Overview
    Table 87. Bayer Multiple Sclerosis Treatment Product
    Table 88. Bayer Revenue in Multiple Sclerosis Treatment Business (2018-2023) & (US$ Million)
    Table 89. Bayer Recent Developments
    Table 90. Biogen Company Details
    Table 91. Biogen Business Overview
    Table 92. Biogen Multiple Sclerosis Treatment Product
    Table 93. Biogen Revenue in Multiple Sclerosis Treatment Business (2018-2023) & (US$ Million)
    Table 94. Biogen Recent Developments
    Table 95. Roche Company Details
    Table 96. Roche Business Overview
    Table 97. Roche Multiple Sclerosis Treatment Product
    Table 98. Roche Revenue in Multiple Sclerosis Treatment Business (2018-2023) & (US$ Million)
    Table 99. Roche Recent Developments
    Table 100. Novartis Company Details
    Table 101. Novartis Business Overview
    Table 102. Novartis Multiple Sclerosis Treatment Product
    Table 103. Novartis Revenue in Multiple Sclerosis Treatment Business (2018-2023) & (US$ Million)
    Table 104. Novartis Recent Developments
    Table 105. CinnaGen Company Details
    Table 106. CinnaGen Business Overview
    Table 107. CinnaGen Multiple Sclerosis Treatment Product
    Table 108. CinnaGen Revenue in Multiple Sclerosis Treatment Business (2018-2023) & (US$ Million)
    Table 109. CinnaGen Recent Developments
    Table 110. Mylan Company Details
    Table 111. Mylan Business Overview
    Table 112. Mylan Multiple Sclerosis Treatment Product
    Table 113. Mylan Revenue in Multiple Sclerosis Treatment Business (2018-2023) & (US$ Million)
    Table 114. Mylan Recent Developments
    Table 115. Bristol-Myers Squibb Company Details
    Table 116. Bristol-Myers Squibb Business Overview
    Table 117. Bristol-Myers Squibb Multiple Sclerosis Treatment Product
    Table 118. Bristol-Myers Squibb Revenue in Multiple Sclerosis Treatment Business (2018-2023) & (US$ Million)
    Table 119. Bristol-Myers Squibb Recent Developments
    Table 120. Janssen Pharmaceuticals Company Details
    Table 121. Janssen Pharmaceuticals Business Overview
    Table 122. Janssen Pharmaceuticals Multiple Sclerosis Treatment Product
    Table 123. Janssen Pharmaceuticals Revenue in Multiple Sclerosis Treatment Business (2018-2023) & (US$ Million)
    Table 124. Janssen Pharmaceuticals Recent Developments
    Table 125. Acorda Therapeutics Company Details
    Table 126. Acorda Therapeutics Business Overview
    Table 127. Acorda Therapeutics Multiple Sclerosis Treatment Product
    Table 128. Acorda Therapeutics Revenue in Multiple Sclerosis Treatment Business (2018-2023) & (US$ Million)
    Table 129. Acorda Therapeutics Recent Developments
    Table 130. Research Programs/Design for This Report
    Table 131. Key Data Information from Secondary Sources
    Table 132. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Multiple Sclerosis Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 2. Global Multiple Sclerosis Treatment Market Share by Type: 2022 VS 2029
    Figure 3. Immunomodulatory Features
    Figure 4. Immunosuppressive Features
    Figure 5. Interferons Features
    Figure 6. Others Features
    Figure 7. Global Multiple Sclerosis Treatment Market Size Growth Rate by Sales Channel, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 8. Global Multiple Sclerosis Treatment Market Share by Sales Channel: 2022 VS 2029
    Figure 9. Hospital Pharmacy Case Studies
    Figure 10. Retail Pharmacy Case Studies
    Figure 11. Online Stores Case Studies
    Figure 12. Multiple Sclerosis Treatment Report Years Considered
    Figure 13. Global Multiple Sclerosis Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 14. Global Multiple Sclerosis Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 15. Global Multiple Sclerosis Treatment Market Share by Region: 2022 VS 2029
    Figure 16. Global Multiple Sclerosis Treatment Market Share by Players in 2022
    Figure 17. Global Top Multiple Sclerosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Sclerosis Treatment as of 2022)
    Figure 18. The Top 10 and 5 Players Market Share by Multiple Sclerosis Treatment Revenue in 2022
    Figure 19. North America Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 20. North America Multiple Sclerosis Treatment Market Share by Type (2018-2029)
    Figure 21. North America Multiple Sclerosis Treatment Market Share by Sales Channel (2018-2029)
    Figure 22. North America Multiple Sclerosis Treatment Market Share by Country (2018-2029)
    Figure 23. United States Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. Canada Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. Europe Multiple Sclerosis Treatment Market Size YoY (2018-2029) & (US$ Million)
    Figure 26. Europe Multiple Sclerosis Treatment Market Share by Type (2018-2029)
    Figure 27. Europe Multiple Sclerosis Treatment Market Share by Sales Channel (2018-2029)
    Figure 28. Europe Multiple Sclerosis Treatment Market Share by Country (2018-2029)
    Figure 29. Germany Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. France Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. U.K. Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Italy Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Russia Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Nordic Countries Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. China Multiple Sclerosis Treatment Market Size YoY (2018-2029) & (US$ Million)
    Figure 36. China Multiple Sclerosis Treatment Market Share by Type (2018-2029)
    Figure 37. China Multiple Sclerosis Treatment Market Share by Sales Channel (2018-2029)
    Figure 38. Asia Multiple Sclerosis Treatment Market Size YoY (2018-2029) & (US$ Million)
    Figure 39. Asia Multiple Sclerosis Treatment Market Share by Type (2018-2029)
    Figure 40. Asia Multiple Sclerosis Treatment Market Share by Sales Channel (2018-2029)
    Figure 41. Asia Multiple Sclerosis Treatment Market Share by Region (2018-2029)
    Figure 42. Japan Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. South Korea Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. China Taiwan Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Southeast Asia Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. India Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 47. Australia Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Multiple Sclerosis Treatment Market Size YoY (2018-2029) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Multiple Sclerosis Treatment Market Share by Type (2018-2029)
    Figure 50. Middle East, Africa, and Latin America Multiple Sclerosis Treatment Market Share by Sales Channel (2018-2029)
    Figure 51. Middle East, Africa, and Latin America Multiple Sclerosis Treatment Market Share by Country (2018-2029)
    Figure 52. Brazil Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 53. Mexico Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 54. Turkey Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 55. Saudi Arabia Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 56. Israel Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 57. GCC Countries Multiple Sclerosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 58. Pfizer Revenue Growth Rate in Multiple Sclerosis Treatment Business (2018-2023)
    Figure 59. Merck & Co Revenue Growth Rate in Multiple Sclerosis Treatment Business (2018-2023)
    Figure 60. Teva Pharmaceutical Revenue Growth Rate in Multiple Sclerosis Treatment Business (2018-2023)
    Figure 61. Sanofi Revenue Growth Rate in Multiple Sclerosis Treatment Business (2018-2023)
    Figure 62. Bayer Revenue Growth Rate in Multiple Sclerosis Treatment Business (2018-2023)
    Figure 63. Biogen Revenue Growth Rate in Multiple Sclerosis Treatment Business (2018-2023)
    Figure 64. Roche Revenue Growth Rate in Multiple Sclerosis Treatment Business (2018-2023)
    Figure 65. Novartis Revenue Growth Rate in Multiple Sclerosis Treatment Business (2018-2023)
    Figure 66. CinnaGen Revenue Growth Rate in Multiple Sclerosis Treatment Business (2018-2023)
    Figure 67. Mylan Revenue Growth Rate in Multiple Sclerosis Treatment Business (2018-2023)
    Figure 68. Bristol-Myers Squibb Revenue Growth Rate in Multiple Sclerosis Treatment Business (2018-2023)
    Figure 69. Janssen Pharmaceuticals Revenue Growth Rate in Multiple Sclerosis Treatment Business (2018-2023)
    Figure 70. Acorda Therapeutics Revenue Growth Rate in Multiple Sclerosis Treatment Business (2018-2023)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Cerebral Palsy Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-36K2790
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Chorea Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-22U5801
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Amyotrophic Lateral Sclerosis (ALS) Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-17W2541
Sun Apr 07 00:00:00 UTC 2024

Add to Cart

Parkinson Disease Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-39X2260
Sun Apr 07 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions